Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat

Fenoldopam mesylate (FM), a selective, postjunctional, dopaminergic (DA1) vasodilator, causes a novel lesion of large caliber splanchnic arteries (100 to 800 microns) in the rat characterized by necrosis of medial smooth muscle cells and hemorrhage. FM does not induce lesions in other vascular beds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of pathology 1989-08, Vol.135 (2), p.339-349
Hauptverfasser: Kerns, WD, Arena, E, Morgan, DG
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 349
container_issue 2
container_start_page 339
container_title The American journal of pathology
container_volume 135
creator Kerns, WD
Arena, E
Morgan, DG
description Fenoldopam mesylate (FM), a selective, postjunctional, dopaminergic (DA1) vasodilator, causes a novel lesion of large caliber splanchnic arteries (100 to 800 microns) in the rat characterized by necrosis of medial smooth muscle cells and hemorrhage. FM does not induce lesions in other vascular beds of the rat or in dogs or monkeys. Dopamine, like FM, causes hemorrhagic lesions of large caliber splanchnic arteries in the rat, as well as fibrinoid necrosis of small caliber arteries (less than 100 microns) of the splanchnic, cerebral, coronary, and renal vascular beds. Dopamine, an alpha- and beta-adrenoceptor and dopaminergic agonist, is used clinically, principally as a pressor agent. Because these arterial lesions were believed to result from the pharmacologic activity of these two compounds, the role of vascular receptor subtypes in their pathogenesis was investigated. Rats were coexposed to either FM or dopamine and a variety of receptor antagonists (alpha, beta, DA1, DA2, and 5HT2). In rats coexposed to the alpha-adrenoreceptor antagonist phenoxybenzamine (PBZ) and either FM or dopamine, the incidence and severity of hemorrhagic lesions of large caliber arteries were increased; PBZ, however, prevented the formation of dopamine-induced fibrinoid lesions in arteries of small caliber. SK&F 83566-C, a selective DA1 dopaminergic receptor antagonist, prevented the induction of FM and dopamine-induced hemorrhagic lesions of large caliber arteries. Rats exposed concurrently to dopamine, phenoxybenzamine, and SK&F 83566-C were free of all arterial lesions. The other receptor antagonists tested did not prevent arterial injury. Thus, the induction of splanchnic arterial lesions in the rat by dopamine and FM is caused by stimulation of, and interaction between, alpha-adrenoceptors and dopaminergic DA1 receptors. Activation of the postjunctional, dopaminergic (DA1) receptor is causally associated with the induction of novel hemorrhagic lesions of large caliber splanchnic arteries in the rat.
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1879911</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2571297</sourcerecordid><originalsourceid>FETCH-LOGICAL-h322t-3993998096668f3c312d75bd2970e4130a1e5450349802e171b70f3c41f55e543</originalsourceid><addsrcrecordid>eNpVkNtKxDAQhoso67r6CEJu9K6QQ9NubgRZPMGCIHodZtvpNkvalKSr7Dv40GZPohAIk_-bL8ycJGMmuUw5U-w0GVNKeaqyjJ4nFyGsYpmLKR0lIy4LxlUxTr7fnEXialK5HlrToV-akkBXEag8HkqPJfaD84GYjgwNkh6Gxi1jHEzYNoMf0BuwxMYX1225al1iRRYbUmPn7M5OWgwbCwPu_McPj04Pw2VyVoMNeHW4J8nH48P77Dmdvz69zO7naSM4H1KhVDxTqvI8n9aiFIxXhVxUcSCKGRMUGMpMUpFFiCMr2KKgkctYLWVMxCS523v79aLFqsRu8GB1700LfqMdGP0_6Uyjl-5Ts2mhFGNRcP1X8Nt5WGvMbw45hBJs7aErTfjFmMoFFbmM3O2ea8yy-TIedWjB2mhlGlY9E1JzLYQSPzePkWM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Kerns, WD ; Arena, E ; Morgan, DG</creator><creatorcontrib>Kerns, WD ; Arena, E ; Morgan, DG</creatorcontrib><description>Fenoldopam mesylate (FM), a selective, postjunctional, dopaminergic (DA1) vasodilator, causes a novel lesion of large caliber splanchnic arteries (100 to 800 microns) in the rat characterized by necrosis of medial smooth muscle cells and hemorrhage. FM does not induce lesions in other vascular beds of the rat or in dogs or monkeys. Dopamine, like FM, causes hemorrhagic lesions of large caliber splanchnic arteries in the rat, as well as fibrinoid necrosis of small caliber arteries (less than 100 microns) of the splanchnic, cerebral, coronary, and renal vascular beds. Dopamine, an alpha- and beta-adrenoceptor and dopaminergic agonist, is used clinically, principally as a pressor agent. Because these arterial lesions were believed to result from the pharmacologic activity of these two compounds, the role of vascular receptor subtypes in their pathogenesis was investigated. Rats were coexposed to either FM or dopamine and a variety of receptor antagonists (alpha, beta, DA1, DA2, and 5HT2). In rats coexposed to the alpha-adrenoreceptor antagonist phenoxybenzamine (PBZ) and either FM or dopamine, the incidence and severity of hemorrhagic lesions of large caliber arteries were increased; PBZ, however, prevented the formation of dopamine-induced fibrinoid lesions in arteries of small caliber. SK&amp;F 83566-C, a selective DA1 dopaminergic receptor antagonist, prevented the induction of FM and dopamine-induced hemorrhagic lesions of large caliber arteries. Rats exposed concurrently to dopamine, phenoxybenzamine, and SK&amp;F 83566-C were free of all arterial lesions. The other receptor antagonists tested did not prevent arterial injury. Thus, the induction of splanchnic arterial lesions in the rat by dopamine and FM is caused by stimulation of, and interaction between, alpha-adrenoceptors and dopaminergic DA1 receptors. Activation of the postjunctional, dopaminergic (DA1) receptor is causally associated with the induction of novel hemorrhagic lesions of large caliber splanchnic arteries in the rat.</description><identifier>ISSN: 0002-9440</identifier><identifier>EISSN: 1525-2191</identifier><identifier>PMID: 2571297</identifier><identifier>CODEN: AJPAA4</identifier><language>eng</language><publisher>Bethesda, MD: ASIP</publisher><subject>Animals ; Arteries - drug effects ; Arteries - pathology ; Benzazepines - toxicity ; Biological and medical sciences ; Cardiovascular Diseases - chemically induced ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - pathology ; Dopamine - toxicity ; Drug toxicity and drugs side effects treatment ; Fenoldopam ; Male ; Medical sciences ; Muscle, Smooth, Vascular - drug effects ; Muscle, Smooth, Vascular - pathology ; Pharmacology. Drug treatments ; Rats ; Rats, Inbred Strains ; Receptors, Adrenergic - physiology ; Receptors, Dopamine - physiology ; Toxicity: cardiovascular system</subject><ispartof>The American journal of pathology, 1989-08, Vol.135 (2), p.339-349</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1879911/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1879911/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19630365$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2571297$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kerns, WD</creatorcontrib><creatorcontrib>Arena, E</creatorcontrib><creatorcontrib>Morgan, DG</creatorcontrib><title>Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat</title><title>The American journal of pathology</title><addtitle>Am J Pathol</addtitle><description>Fenoldopam mesylate (FM), a selective, postjunctional, dopaminergic (DA1) vasodilator, causes a novel lesion of large caliber splanchnic arteries (100 to 800 microns) in the rat characterized by necrosis of medial smooth muscle cells and hemorrhage. FM does not induce lesions in other vascular beds of the rat or in dogs or monkeys. Dopamine, like FM, causes hemorrhagic lesions of large caliber splanchnic arteries in the rat, as well as fibrinoid necrosis of small caliber arteries (less than 100 microns) of the splanchnic, cerebral, coronary, and renal vascular beds. Dopamine, an alpha- and beta-adrenoceptor and dopaminergic agonist, is used clinically, principally as a pressor agent. Because these arterial lesions were believed to result from the pharmacologic activity of these two compounds, the role of vascular receptor subtypes in their pathogenesis was investigated. Rats were coexposed to either FM or dopamine and a variety of receptor antagonists (alpha, beta, DA1, DA2, and 5HT2). In rats coexposed to the alpha-adrenoreceptor antagonist phenoxybenzamine (PBZ) and either FM or dopamine, the incidence and severity of hemorrhagic lesions of large caliber arteries were increased; PBZ, however, prevented the formation of dopamine-induced fibrinoid lesions in arteries of small caliber. SK&amp;F 83566-C, a selective DA1 dopaminergic receptor antagonist, prevented the induction of FM and dopamine-induced hemorrhagic lesions of large caliber arteries. Rats exposed concurrently to dopamine, phenoxybenzamine, and SK&amp;F 83566-C were free of all arterial lesions. The other receptor antagonists tested did not prevent arterial injury. Thus, the induction of splanchnic arterial lesions in the rat by dopamine and FM is caused by stimulation of, and interaction between, alpha-adrenoceptors and dopaminergic DA1 receptors. Activation of the postjunctional, dopaminergic (DA1) receptor is causally associated with the induction of novel hemorrhagic lesions of large caliber splanchnic arteries in the rat.</description><subject>Animals</subject><subject>Arteries - drug effects</subject><subject>Arteries - pathology</subject><subject>Benzazepines - toxicity</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular Diseases - chemically induced</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - pathology</subject><subject>Dopamine - toxicity</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Fenoldopam</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscle, Smooth, Vascular - pathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Receptors, Adrenergic - physiology</subject><subject>Receptors, Dopamine - physiology</subject><subject>Toxicity: cardiovascular system</subject><issn>0002-9440</issn><issn>1525-2191</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkNtKxDAQhoso67r6CEJu9K6QQ9NubgRZPMGCIHodZtvpNkvalKSr7Dv40GZPohAIk_-bL8ycJGMmuUw5U-w0GVNKeaqyjJ4nFyGsYpmLKR0lIy4LxlUxTr7fnEXialK5HlrToV-akkBXEag8HkqPJfaD84GYjgwNkh6Gxi1jHEzYNoMf0BuwxMYX1225al1iRRYbUmPn7M5OWgwbCwPu_McPj04Pw2VyVoMNeHW4J8nH48P77Dmdvz69zO7naSM4H1KhVDxTqvI8n9aiFIxXhVxUcSCKGRMUGMpMUpFFiCMr2KKgkctYLWVMxCS523v79aLFqsRu8GB1700LfqMdGP0_6Uyjl-5Ts2mhFGNRcP1X8Nt5WGvMbw45hBJs7aErTfjFmMoFFbmM3O2ea8yy-TIedWjB2mhlGlY9E1JzLYQSPzePkWM</recordid><startdate>19890801</startdate><enddate>19890801</enddate><creator>Kerns, WD</creator><creator>Arena, E</creator><creator>Morgan, DG</creator><general>ASIP</general><general>American Society for Investigative Pathology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>19890801</creationdate><title>Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat</title><author>Kerns, WD ; Arena, E ; Morgan, DG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h322t-3993998096668f3c312d75bd2970e4130a1e5450349802e171b70f3c41f55e543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Animals</topic><topic>Arteries - drug effects</topic><topic>Arteries - pathology</topic><topic>Benzazepines - toxicity</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular Diseases - chemically induced</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - pathology</topic><topic>Dopamine - toxicity</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Fenoldopam</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscle, Smooth, Vascular - pathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Receptors, Adrenergic - physiology</topic><topic>Receptors, Dopamine - physiology</topic><topic>Toxicity: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kerns, WD</creatorcontrib><creatorcontrib>Arena, E</creatorcontrib><creatorcontrib>Morgan, DG</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kerns, WD</au><au>Arena, E</au><au>Morgan, DG</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat</atitle><jtitle>The American journal of pathology</jtitle><addtitle>Am J Pathol</addtitle><date>1989-08-01</date><risdate>1989</risdate><volume>135</volume><issue>2</issue><spage>339</spage><epage>349</epage><pages>339-349</pages><issn>0002-9440</issn><eissn>1525-2191</eissn><coden>AJPAA4</coden><abstract>Fenoldopam mesylate (FM), a selective, postjunctional, dopaminergic (DA1) vasodilator, causes a novel lesion of large caliber splanchnic arteries (100 to 800 microns) in the rat characterized by necrosis of medial smooth muscle cells and hemorrhage. FM does not induce lesions in other vascular beds of the rat or in dogs or monkeys. Dopamine, like FM, causes hemorrhagic lesions of large caliber splanchnic arteries in the rat, as well as fibrinoid necrosis of small caliber arteries (less than 100 microns) of the splanchnic, cerebral, coronary, and renal vascular beds. Dopamine, an alpha- and beta-adrenoceptor and dopaminergic agonist, is used clinically, principally as a pressor agent. Because these arterial lesions were believed to result from the pharmacologic activity of these two compounds, the role of vascular receptor subtypes in their pathogenesis was investigated. Rats were coexposed to either FM or dopamine and a variety of receptor antagonists (alpha, beta, DA1, DA2, and 5HT2). In rats coexposed to the alpha-adrenoreceptor antagonist phenoxybenzamine (PBZ) and either FM or dopamine, the incidence and severity of hemorrhagic lesions of large caliber arteries were increased; PBZ, however, prevented the formation of dopamine-induced fibrinoid lesions in arteries of small caliber. SK&amp;F 83566-C, a selective DA1 dopaminergic receptor antagonist, prevented the induction of FM and dopamine-induced hemorrhagic lesions of large caliber arteries. Rats exposed concurrently to dopamine, phenoxybenzamine, and SK&amp;F 83566-C were free of all arterial lesions. The other receptor antagonists tested did not prevent arterial injury. Thus, the induction of splanchnic arterial lesions in the rat by dopamine and FM is caused by stimulation of, and interaction between, alpha-adrenoceptors and dopaminergic DA1 receptors. Activation of the postjunctional, dopaminergic (DA1) receptor is causally associated with the induction of novel hemorrhagic lesions of large caliber splanchnic arteries in the rat.</abstract><cop>Bethesda, MD</cop><pub>ASIP</pub><pmid>2571297</pmid><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9440
ispartof The American journal of pathology, 1989-08, Vol.135 (2), p.339-349
issn 0002-9440
1525-2191
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1879911
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Animals
Arteries - drug effects
Arteries - pathology
Benzazepines - toxicity
Biological and medical sciences
Cardiovascular Diseases - chemically induced
Cardiovascular Diseases - etiology
Cardiovascular Diseases - pathology
Dopamine - toxicity
Drug toxicity and drugs side effects treatment
Fenoldopam
Male
Medical sciences
Muscle, Smooth, Vascular - drug effects
Muscle, Smooth, Vascular - pathology
Pharmacology. Drug treatments
Rats
Rats, Inbred Strains
Receptors, Adrenergic - physiology
Receptors, Dopamine - physiology
Toxicity: cardiovascular system
title Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A38%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20dopaminergic%20and%20adrenergic%20receptors%20in%20the%20pathogenesis%20of%20arterial%20lesions%20induced%20by%20fenoldopam%20mesylate%20and%20dopamine%20in%20the%20rat&rft.jtitle=The%20American%20journal%20of%20pathology&rft.au=Kerns,%20WD&rft.date=1989-08-01&rft.volume=135&rft.issue=2&rft.spage=339&rft.epage=349&rft.pages=339-349&rft.issn=0002-9440&rft.eissn=1525-2191&rft.coden=AJPAA4&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E2571297%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2571297&rfr_iscdi=true